BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17656010)

  • 1. CD133-enriched CD34(-) (CD33/CD38/CD71)(-) cord blood cells acquire CD34 prior to cell division and hematopoietic activity is exclusively associated with CD34 expression.
    Götze KS; Schiemann M; Marz S; Jacobs VR; Debus G; Peschel C; Oostendorp RA
    Exp Hematol; 2007 Sep; 35(9):1408-14. PubMed ID: 17656010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncostatin M-mediated regulation of KIT-ligand-induced extracellular signal-regulated kinase signaling maintains hematopoietic repopulating activity of Lin-CD34+CD133+ cord blood cells.
    Oostendorp RA; Gilfillan S; Parmar A; Schiemann M; Marz S; Niemeyer M; Schill S; Hammerschmid E; Jacobs VR; Peschel C; Götze KS
    Stem Cells; 2008 Aug; 26(8):2164-72. PubMed ID: 18499891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells.
    Kobari L; Giarratana MC; Pflumio F; Izac B; Coulombel L; Douay L
    J Hematother Stem Cell Res; 2001 Apr; 10(2):273-81. PubMed ID: 11359674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a lineage-negative stem-progenitor cell population optimized for ex vivo expansion and enriched for LTC-IC.
    Forraz N; Pettengell R; McGuckin CP
    Stem Cells; 2004; 22(1):100-8. PubMed ID: 14688396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of CFU-GM, BFU-E and endothelial progenitor cells using ex vivo expansion of selected cord blood CD133(+) and CD34(+) cells.
    Lu X; Baudouin SV; Gillespie JI; Anderson JJ; Dickinson AM
    Cytotherapy; 2007; 9(3):292-300. PubMed ID: 17464761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine expansion culture of cord blood CD34+ cells induces marked and sustained changes in adhesion receptor and CXCR4 expressions.
    Denning-Kendall P; Singha S; Bradley B; Hows J
    Stem Cells; 2003; 21(1):61-70. PubMed ID: 12529552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on the dynamics of biological characteristics of CD133+ cells from human umbilical cord blood during short-term culture].
    Hao SG; Sun GL; Wu WL; Wu YL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):569-75. PubMed ID: 14706136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haematopoietic repopulating activity in human cord blood CD133+ quiescent cells.
    Boxall SA; Cook GP; Pearce D; Bonnet D; El-Sherbiny YM; Blundell MP; Howe SJ; Leek JP; Markham AF; de Wynter EA
    Bone Marrow Transplant; 2009 Apr; 43(8):627-35. PubMed ID: 18997827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors.
    de Wynter EA; Buck D; Hart C; Heywood R; Coutinho LH; Clayton A; Rafferty JA; Burt D; Guenechea G; Bueren JA; Gagen D; Fairbairn LJ; Lord BI; Testa NG
    Stem Cells; 1998; 16(6):387-96. PubMed ID: 9831864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine.
    Peled T; Mandel J; Goudsmid RN; Landor C; Hasson N; Harati D; Austin M; Hasson A; Fibach E; Shpall EJ; Nagler A
    Cytotherapy; 2004; 6(4):344-55. PubMed ID: 16146887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth factor receptors in hematopoietic stem cells: EPH family expression in CD34+ and CD133+ cell populations from mobilized peripheral blood.
    Lazarova P; Wu Q; Kvalheim G; Suo Z; Haakenstad KW; Metodiev K; Nesland JM
    Int J Immunopathol Pharmacol; 2006; 19(1):49-56. PubMed ID: 16569339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro proliferative and differentiating characteristics of CD133(+) and CD34(+) cord blood cells in the presence of thrombopoietin (TPO) or erythropoietin (EPO). Potential implications for hematopoietic cell transplantation.
    Dimitriou H; Vorgia P; Stiakaki E; Mavroudis D; Markaki EA; Koumantakis E; Kalmanti M
    Leuk Res; 2003 Dec; 27(12):1143-51. PubMed ID: 12921953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A functional hierarchy among the CD34+ hematopoietic cells based on in vitro proliferative and differentiative potential of AC133+CD34(bright) and AC133(dim/)-CD34+ human cord blood cells.
    Goussetis E; Theodosaki M; Paterakis G; Peristeri J; Petropoulos D; Kitra V; Papassarandis C; Graphakos S
    J Hematother Stem Cell Res; 2000 Dec; 9(6):827-40. PubMed ID: 11177594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of serum-free ex vivo-expanded hematopoietic stem cells derived from human umbilical cord blood CD133(+) cells.
    Yao CL; Feng YH; Lin XZ; Chu IM; Hsieh TB; Hwang SM
    Stem Cells Dev; 2006 Feb; 15(1):70-8. PubMed ID: 16522164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
    Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM
    Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential expression of the vasoactive intestinal peptide (VIP) receptor VPAC1 in human cord blood-derived CD34+CD38- cells: possible role of VIP as a growth-promoting factor for hematopoietic stem/progenitor cells.
    Kawakami M; Kimura T; Kishimoto Y; Tatekawa T; Baba Y; Nishizaki T; Matsuzaki N; Taniguchi Y; Yoshihara S; Ikegame K; Shirakata T; Nishida S; Masuda T; Hosen N; Tsuboi A; Oji Y; Oka Y; Ogawa H; Sonoda Y; Sugiyama H; Kawase I; Soma T
    Leukemia; 2004 May; 18(5):912-21. PubMed ID: 14999295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of transcription factor Oct-4 and other embryonic genes in CD133 positive cells from human umbilical cord blood.
    Baal N; Reisinger K; Jahr H; Bohle RM; Liang O; Münstedt K; Rao CV; Preissner KT; Zygmunt MT
    Thromb Haemost; 2004 Oct; 92(4):767-75. PubMed ID: 15467907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional differences between subpopulations of mobilized peripheral blood-derived CD34+ cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens.
    Sakabe H; Ohmizono Y; Tanimukai S; Kimura T; Mori KJ; Abe T; Sonoda Y
    Stem Cells; 1997; 15(1):73-81. PubMed ID: 9007225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human CD34+ CD133+ hematopoietic stem cells cultured with growth factors including Angptl5 efficiently engraft adult NOD-SCID Il2rγ-/- (NSG) mice.
    Drake AC; Khoury M; Leskov I; Iliopoulou BP; Fragoso M; Lodish H; Chen J
    PLoS One; 2011 Apr; 6(4):e18382. PubMed ID: 21559522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expansion of erythroid progenitors and CD34+ cells by umbilical cord blood mononuclear cells].
    Zhang JX; Mao P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):429-33. PubMed ID: 15972135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.